Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
4.250
-0.030 (-0.70%)
Nov 21, 2024, 11:01 AM EST - Market open
Skye Bioscience Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 11.11 | 7.7 | 12.3 | 4.92 | 4.34 | 4.39 | |
Research & Development | 12.5 | 5.82 | 6.01 | 2.93 | 1.94 | 2.24 | |
Operating Expenses | 23.62 | 13.52 | 18.31 | 7.85 | 6.29 | 6.63 | |
Operating Income | -23.62 | -13.52 | -18.31 | -7.85 | -6.29 | -6.63 | |
Interest Expense | -1.62 | -0.91 | -0.67 | -0.77 | -0.71 | -1 | |
Interest & Investment Income | 2.35 | 0.1 | 0.02 | 0 | 0 | 0 | |
Other Non Operating Income (Expenses) | 0 | 0 | -0.06 | -0.02 | 0.44 | 9.41 | |
EBT Excluding Unusual Items | -22.89 | -14.33 | -19.02 | -8.64 | -6.56 | 1.78 | |
Gain (Loss) on Sale of Assets | 1.22 | -0.31 | - | - | - | - | |
Asset Writedown | 0.05 | -0.41 | -0.46 | - | - | - | |
Other Unusual Items | - | -1.38 | - | 0.12 | - | -0.73 | |
Pretax Income | -21.23 | -37.64 | -19.47 | -8.52 | -6.56 | 1.05 | |
Income Tax Expense | 0.01 | 0 | 0.01 | 0 | 0 | 0 | |
Net Income | -21.24 | -37.64 | -19.48 | -8.52 | -6.56 | 1.05 | |
Net Income to Common | -21.24 | -37.64 | -19.48 | -8.52 | -6.56 | 1.05 | |
Shares Outstanding (Basic) | 30 | 7 | 2 | 2 | 1 | 1 | |
Shares Outstanding (Diluted) | 30 | 7 | 2 | 2 | 1 | 1 | |
Shares Change (YoY) | 537.83% | 215.43% | 36.56% | 75.70% | 36.48% | 39.95% | |
EPS (Basic) | -0.72 | -5.37 | -8.77 | -5.24 | -7.11 | 1.95 | |
EPS (Diluted) | -0.72 | -5.37 | -8.77 | -5.24 | -7.46 | -12.09 | |
Free Cash Flow | -22.47 | -13.96 | -12.84 | -6.57 | -6.06 | -6.03 | |
Free Cash Flow Per Share | -0.76 | -1.99 | -5.78 | -4.04 | -6.55 | -8.89 | |
EBITDA | -23.46 | -13.4 | -18.2 | -7.81 | -6.29 | -6.63 | |
D&A For EBITDA | 0.15 | 0.12 | 0.11 | 0.03 | 0 | 0 | |
EBIT | -23.62 | -13.52 | -18.31 | -7.85 | -6.29 | -6.63 | |
Effective Tax Rate | - | - | - | - | - | 0.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.